Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist

Abu Baker M. Abdel-Aal, Vani Lakshminarayanan, Pamela Thompson, Nitin Supekar, Judy M. Bradley, Margreet A. Wolfert, Peter A. Cohen, Sandra J. Gendler, Geert Jan Boons

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds